Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Backs Off Mircera Suit In India

Executive Summary

Roche has dropped its suit against Intas Pharmaceuticals Ltd. over the alleged infringement of its patents pertaining to Mircera (methoxy polyethylene glycol-epoetin beta), after the Indian firm apparently established that its product is "different". Both sides, though, seemed to keep the matter alive, suggesting that they would seek appropriate remedies in the event of fresh "cause of action".

Advertisement

Related Content

Indian Avastin Versions Head For Debut; Watch Off-Label Space
Indian Herceptin Biosimilars Case Simmers

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC065326

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel